{"id":39810,"date":"2020-04-09T10:20:25","date_gmt":"2020-04-09T17:20:25","guid":{"rendered":"https:\/\/www.enxmag.com\/twii\/?p=39810"},"modified":"2020-04-09T10:20:29","modified_gmt":"2020-04-09T17:20:29","slug":"xerox-and-vortran-medical-partnering-to-mass-produce-disposable-ventilators","status":"publish","type":"post","link":"https:\/\/www.enxmag.com\/twii\/feature-articles\/2020\/04\/xerox-and-vortran-medical-partnering-to-mass-produce-disposable-ventilators\/","title":{"rendered":"Xerox and Vortran Medical Partnering to Mass Produce Disposable Ventilators"},"content":{"rendered":"\n
\"\"<\/figure><\/div>\n\n\n\n

Xerox Holdings Corporation (NYSE: XRX) and Vortran Medical\nTechnology are teaming up to speed and scale production of Vortran\u2019s GO2Vent\nventilator and related Airway Pressure Monitor (APM-Plus) for hospitals and\nemergency response units fighting the battle against COVID-19.<\/p>\n\n\n\n

The two companies expect to work together to quickly respond\nto the shortage of critical ventilation equipment necessary to support patients\nbreathing. Assuming a stable supply of essential parts, the companies will be\nrapidly scaling up production from approximately 40,000 ventilators in April to\nbetween 150,000 and 200,000 ventilators a month by June. Together, Xerox and\nVortran could produce as many as 1 million ventilators in the coming months.<\/p>\n\n\n\n

While the GO2Vent is not a replacement for ventilators found\nin intensive care units (ICUs), it is widely used in emergency situations,\ninter-hospital transport and MRIs. Given the shortage of ICU-grade ventilators,\nmedical professionals are utilizing tools like this and other technology to\nsupport patients who do not yet or no longer need an ICU-level breathing\ndevice, which can be freed up for another patient.   <\/p>\n\n\n\n

\u201cOur smartest minds met (virtually) with Vortran\u2019s smartest minds and figured out how to mass-produce this critical technology,\u201d said John Visentin, vice chairman and CEO, Xerox. \u201cWe want to help make sure doctors, nurses and paramedics on the frontlines have the resources they need to help the rising number of patients with COVID-19.\u201d<\/p>\n\n\n\n

Xerox plans to manufacture these FDA-approved ventilators and APM-Plus devices at its facility outside of Rochester, New York, where the company was founded and maintains a large presence. Vortran will continue to manufacture ventilators at its current facility in Sacramento, California.<\/p>\n\n\n\n

\u201cThe partnership with Xerox has one clear goal \u2013 to help save as many lives as possible. With Vortran\u2019s proven technology and Xerox\u2019s ability to hyper-scale manufacturing, we believe we can supply health care providers as many as 1 million ventilators in the coming months,\u201d said Vortran co-founder and CEO, Gordon A. Wong, M.D. \u201cFor all of us, this will be the most important thing we ever do.\u201d<\/p>\n\n\n\n

Vortran\u2019s GO2Vent was designed for emergency use, natural\ndisasters and disease outbreaks such as the COVID-19 pandemic. A gas-operated,\ndisposable ventilator that can be set-up within minutes and discarded after use\nby a single patient, it provides support via a secure airway and can be\noperated on a compressor, oxygen or air with a minimum of 10 liters per minute\nflow rates.<\/p>\n\n\n\n

The GO2Vent can provide continuous ventilatory support for up to 30 days and operates independent of Vortran\u2019s APM-Plus. The APM-Plus is a battery-operated, portable device that connects to a GO2Vent and provides enhanced monitoring of patient status and key respiratory parameters. Given the need to confirm key supplies, the companies are actively assessing how quickly production can ramp for the APM-Plus devices. <\/p>\n\n\n\n

In addition to scaling up production of the GO2Vent and APM-Plus, Xerox and Vortran expect to compile and analyze data and feedback from healthcare professionals on the frontlines of the battle against COVID-19 in order to design and mass-produce external, in-line modifications that can be added to the GO2Vent to expand the potential applications of this life-saving equipment.<\/p>\n\n\n\n

Both Xerox and Vortran will distribute the products.<\/p>\n\n\n\n

###<\/p>\n\n\n\n

About Xerox<\/strong>
Xerox Holdings Corporation<\/a> makes every day work better. We are a workplace technology company building and integrating software and hardware for enterprises large and small. As customers seek to manage information across digital and physical platforms, Xerox delivers a seamless, secure and sustainable experience. Whether inventing the copier, Ethernet, the laser printer or more, Xerox has long defined the modern work experience. <\/p>\n\n\n\n

About Vortran <\/strong>
Vortran Medical Technology<\/a> has been providing medical device excellence since 1983. We are a research, development, and manufacturing company of advanced medical respiratory and ambulatory devices. We serve domestic and international markets with a superior line of products for hospitals, emergency medical services (EMS), disaster preparedness, and MRI\/CT applications in hospitals, acute care, post-acute, homecare and EMS situations. <\/p>\n","protected":false},"excerpt":{"rendered":"

Xerox Holdings Corporation (NYSE: XRX) and Vortran Medical Technology are teaming up to speed and scale production of Vortran\u2019s GO2Vent ventilator and related Airway Pressure Monitor (APM-Plus) for hospitals and emergency response units fighting the battle against COVID-19. The two companies expect to work together to quickly respond to the shortage of critical ventilation equipment necessary to support patients breathing. Assuming a stable supply of essential parts, the companies will be rapidly scaling up production from approximately 40,000 ventilators in April to between 150,000 and 200,000 ventilators a month by June. Together, Xerox and Vortran could produce as many as 1 million ventilators in the coming months. While the GO2Vent is not a replacement for ventilators found in intensive care units (ICUs), it is widely used in emergency situations, inter-hospital transport and MRIs. Given the shortage of ICU-grade ventilators, medical professionals are utilizing tools like this and other technology to support patients who do not yet or no longer need an ICU-level breathing device, which can be freed up for another patient.   \u201cOur smartest minds met (virtually) with Vortran\u2019s smartest minds and figured out how to mass-produce this critical technology,\u201d said John Visentin, vice chairman and CEO, Xerox. \u201cWe want to help make sure doctors, nurses and paramedics on the frontlines have the resources they need to help the rising number of patients with COVID-19.\u201d Xerox plans to manufacture these FDA-approved ventilators and APM-Plus devices at its facility outside of Rochester, New York, where the company was founded and maintains a large presence. Vortran will continue to manufacture ventilators at its current facility in Sacramento, California. \u201cThe partnership with Xerox has one clear goal \u2013 to help save as many lives as possible. With Vortran\u2019s proven technology and Xerox\u2019s ability to hyper-scale manufacturing, we believe we can supply health care providers as many as 1 million ventilators in the coming months,\u201d said Vortran co-founder and CEO, Gordon A. Wong, M.D. \u201cFor all of us, this will be the most important thing we ever do.\u201d Vortran\u2019s GO2Vent was designed for emergency use, natural disasters and disease outbreaks such as the COVID-19 pandemic. A gas-operated, disposable ventilator that can be set-up within minutes and discarded after use by a single patient, it provides support via a secure airway and can be operated on a compressor, oxygen or air with a minimum of 10 liters per minute flow rates. The GO2Vent can provide continuous ventilatory support for up to 30 days and operates independent of Vortran\u2019s APM-Plus. The APM-Plus is a battery-operated, portable device that connects to a GO2Vent and provides enhanced monitoring of patient status and key respiratory parameters. Given the need to confirm key supplies, the companies are actively assessing how quickly production can ramp for the APM-Plus devices. In addition to scaling up production of the GO2Vent and APM-Plus, Xerox and Vortran expect to compile and analyze data and feedback from healthcare professionals on the frontlines of the battle against COVID-19 in order to design and mass-produce external, in-line modifications that can be added to the GO2Vent to expand the potential applications of this life-saving equipment. Both Xerox and Vortran will distribute the products. ### About XeroxXerox Holdings Corporation makes every day work better. We are a workplace technology company building and integrating software and hardware for enterprises large and small. As customers seek to manage information across digital and physical platforms, Xerox delivers a seamless, secure and sustainable experience. Whether inventing the copier, Ethernet, the laser printer or more, Xerox has long defined the modern work experience. About Vortran Vortran Medical Technology has been providing medical device excellence since 1983. We are a research, development, and manufacturing company of advanced medical respiratory and ambulatory devices. We serve domestic and international markets with a superior line of products for hospitals, emergency medical services (EMS), disaster preparedness, and MRI\/CT applications in hospitals, acute care, post-acute, homecare and EMS situations.<\/p>\n","protected":false},"author":66,"featured_media":39811,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1650,82,87,1638],"tags":[362],"_links":{"self":[{"href":"https:\/\/www.enxmag.com\/twii\/wp-json\/wp\/v2\/posts\/39810"}],"collection":[{"href":"https:\/\/www.enxmag.com\/twii\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enxmag.com\/twii\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enxmag.com\/twii\/wp-json\/wp\/v2\/users\/66"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enxmag.com\/twii\/wp-json\/wp\/v2\/comments?post=39810"}],"version-history":[{"count":1,"href":"https:\/\/www.enxmag.com\/twii\/wp-json\/wp\/v2\/posts\/39810\/revisions"}],"predecessor-version":[{"id":39812,"href":"https:\/\/www.enxmag.com\/twii\/wp-json\/wp\/v2\/posts\/39810\/revisions\/39812"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.enxmag.com\/twii\/wp-json\/wp\/v2\/media\/39811"}],"wp:attachment":[{"href":"https:\/\/www.enxmag.com\/twii\/wp-json\/wp\/v2\/media?parent=39810"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enxmag.com\/twii\/wp-json\/wp\/v2\/categories?post=39810"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enxmag.com\/twii\/wp-json\/wp\/v2\/tags?post=39810"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}